Cargando…

Impact of risk communication on patient’s safety during the pandemic

More than 2 years has passed since the pandemic was declared in 2019 due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was later declared to be the pathogen causing coronavirus disease 2019 (COVID-19). During this time, many healthcare systems faced numerous challenges t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuluaga-Arias, Heyde-Patricia, Alkhakany, Mayada, Younus, Manal M., Sefiani, Houda, Caro-Rojas, Angela, Al-Zubiedi, Sameh, Albalawi, Wafi F., Alshammari, Thamir M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026095/
https://www.ncbi.nlm.nih.gov/pubmed/36949767
http://dx.doi.org/10.1177/20420986231159752
_version_ 1784909470648762368
author Zuluaga-Arias, Heyde-Patricia
Alkhakany, Mayada
Younus, Manal M.
Sefiani, Houda
Caro-Rojas, Angela
Al-Zubiedi, Sameh
Albalawi, Wafi F.
Alshammari, Thamir M.
author_facet Zuluaga-Arias, Heyde-Patricia
Alkhakany, Mayada
Younus, Manal M.
Sefiani, Houda
Caro-Rojas, Angela
Al-Zubiedi, Sameh
Albalawi, Wafi F.
Alshammari, Thamir M.
author_sort Zuluaga-Arias, Heyde-Patricia
collection PubMed
description More than 2 years has passed since the pandemic was declared in 2019 due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was later declared to be the pathogen causing coronavirus disease 2019 (COVID-19). During this time, many healthcare systems faced numerous challenges to control the high morbidity and mortality of the disease. Unlike previous pandemics, the actions against this pandemic started quickly on both the global and country levels. These actions were, scientifically, to study the virus as well as transmission process and to develop medications and vaccines against it. Also, we had to protect people from transmission by knowing how best to apply precautionary methods. However, there were some unexpected negative consequences of the pandemic and one of those the World Health Organization (WHO) called ‘infodemic’. This term infodemic refers to the manipulation of a population’s behavior in the assessment of information (or, more accurately, lack of assessment) related to the use of medications, particularly vaccines. Unfortunately, even with positive development in science, there was limited and often contradictory amount of information on the safety and efficacy profile of drugs and vaccines. Therefore, this made it harder for public health agencies to determine the impact of the incidence of adverse reactions and events associated with interventions such as vaccines. Hence, risk communication needs to be emphasized during any pandemic, as ignoring risk communications to different stakeholders could undermine all well-intended therapeutic interventions. Given this, it is important that the different stakeholders involved (health authorities, societies, healthcare professionals, etc.) assess the different behavioral patterns within their respective populations and propose appropriate strategies to act. Such an approach complement having risk management and communication plans for this and future pandemics. The aim of this article is to explore how information management, risk management, and risk communication during the pandemic can provide valuable lessons for the future. PLAIN LANGUAGE SUMMARY: Impact of risk communication on patient’s safety during the pandemic More than 2 years have gone by since the pandemic was declared in 2019 due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Many challenges have been confronted by the healthcare system during this time to control the high impact of this disease. This pandemic, unlike others that humanity has faced, is characterized by a special feature: today, we have an enormous amount of information only a click away. This situation has been of great benefit to humanity and has allowed the development of science; nevertheless, misinformation (infodemics) has been a major problem, which has revealed the behavior of the population regarding the evaluation of information (or better, lack of assessment) related to the use of medications and particularly of vaccines. Given this, it is important that the different people involved (health authorities, societies, healthcare professionals, etc.) assess the behavior and propose appropriate strategies to act and have plans for this and future pandemics. This article intends to explore from the authors’ perspective how information management, risk management, and risk communication during the pandemic can provide valuable lessons for the future.
format Online
Article
Text
id pubmed-10026095
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-100260952023-03-21 Impact of risk communication on patient’s safety during the pandemic Zuluaga-Arias, Heyde-Patricia Alkhakany, Mayada Younus, Manal M. Sefiani, Houda Caro-Rojas, Angela Al-Zubiedi, Sameh Albalawi, Wafi F. Alshammari, Thamir M. Ther Adv Drug Saf Self-Medication and Pharmacovigilance in the Era of Infodemic More than 2 years has passed since the pandemic was declared in 2019 due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was later declared to be the pathogen causing coronavirus disease 2019 (COVID-19). During this time, many healthcare systems faced numerous challenges to control the high morbidity and mortality of the disease. Unlike previous pandemics, the actions against this pandemic started quickly on both the global and country levels. These actions were, scientifically, to study the virus as well as transmission process and to develop medications and vaccines against it. Also, we had to protect people from transmission by knowing how best to apply precautionary methods. However, there were some unexpected negative consequences of the pandemic and one of those the World Health Organization (WHO) called ‘infodemic’. This term infodemic refers to the manipulation of a population’s behavior in the assessment of information (or, more accurately, lack of assessment) related to the use of medications, particularly vaccines. Unfortunately, even with positive development in science, there was limited and often contradictory amount of information on the safety and efficacy profile of drugs and vaccines. Therefore, this made it harder for public health agencies to determine the impact of the incidence of adverse reactions and events associated with interventions such as vaccines. Hence, risk communication needs to be emphasized during any pandemic, as ignoring risk communications to different stakeholders could undermine all well-intended therapeutic interventions. Given this, it is important that the different stakeholders involved (health authorities, societies, healthcare professionals, etc.) assess the different behavioral patterns within their respective populations and propose appropriate strategies to act. Such an approach complement having risk management and communication plans for this and future pandemics. The aim of this article is to explore how information management, risk management, and risk communication during the pandemic can provide valuable lessons for the future. PLAIN LANGUAGE SUMMARY: Impact of risk communication on patient’s safety during the pandemic More than 2 years have gone by since the pandemic was declared in 2019 due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Many challenges have been confronted by the healthcare system during this time to control the high impact of this disease. This pandemic, unlike others that humanity has faced, is characterized by a special feature: today, we have an enormous amount of information only a click away. This situation has been of great benefit to humanity and has allowed the development of science; nevertheless, misinformation (infodemics) has been a major problem, which has revealed the behavior of the population regarding the evaluation of information (or better, lack of assessment) related to the use of medications and particularly of vaccines. Given this, it is important that the different people involved (health authorities, societies, healthcare professionals, etc.) assess the behavior and propose appropriate strategies to act and have plans for this and future pandemics. This article intends to explore from the authors’ perspective how information management, risk management, and risk communication during the pandemic can provide valuable lessons for the future. SAGE Publications 2023-03-17 /pmc/articles/PMC10026095/ /pubmed/36949767 http://dx.doi.org/10.1177/20420986231159752 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Self-Medication and Pharmacovigilance in the Era of Infodemic
Zuluaga-Arias, Heyde-Patricia
Alkhakany, Mayada
Younus, Manal M.
Sefiani, Houda
Caro-Rojas, Angela
Al-Zubiedi, Sameh
Albalawi, Wafi F.
Alshammari, Thamir M.
Impact of risk communication on patient’s safety during the pandemic
title Impact of risk communication on patient’s safety during the pandemic
title_full Impact of risk communication on patient’s safety during the pandemic
title_fullStr Impact of risk communication on patient’s safety during the pandemic
title_full_unstemmed Impact of risk communication on patient’s safety during the pandemic
title_short Impact of risk communication on patient’s safety during the pandemic
title_sort impact of risk communication on patient’s safety during the pandemic
topic Self-Medication and Pharmacovigilance in the Era of Infodemic
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026095/
https://www.ncbi.nlm.nih.gov/pubmed/36949767
http://dx.doi.org/10.1177/20420986231159752
work_keys_str_mv AT zuluagaariasheydepatricia impactofriskcommunicationonpatientssafetyduringthepandemic
AT alkhakanymayada impactofriskcommunicationonpatientssafetyduringthepandemic
AT younusmanalm impactofriskcommunicationonpatientssafetyduringthepandemic
AT sefianihouda impactofriskcommunicationonpatientssafetyduringthepandemic
AT carorojasangela impactofriskcommunicationonpatientssafetyduringthepandemic
AT alzubiedisameh impactofriskcommunicationonpatientssafetyduringthepandemic
AT albalawiwafif impactofriskcommunicationonpatientssafetyduringthepandemic
AT alshammarithamirm impactofriskcommunicationonpatientssafetyduringthepandemic